Top Markets
#1 SAFEcoin SAFEcoin +59.28%
#2 Zora Zora +29.49%
#3 AI XOVIA AI XOVIA +28.62%
#4 Full Moon Full Moon +19.62%
#5 Merlin's Seal BTC Merlin's Seal BTC +16.10%
#6 0G 0G +14.98%
#7 Axelar Axelar +14.88%
#8 Bless Bless +13.79%
#9 VVS Finance VVS Finance +13.64%
#10 Apertum Apertum +12.30%
Coin of the day
SAFEcoin SAFEcoin
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Silverback Therapeutics, Inc. Silverback Therapeutics, Inc.

Silverback Therapeutics, Inc.

SBTX
Pozycja w akcjach #12787
Silverback Therapeutics, Inc. operates as a biotechnology firm dedicated to... Silverback Therapeutics, Inc. operates as a biotechnology firm dedicated to devising tissue-specific drug candidates aimed at addressing chronic viral infections, various cancers, and other significant medical conditions. Among its pipeline, SBT8230 stands out as a treatment for chronic hepatitis B virus, working by stimulating an antiviral immune response through the precise activation of TLR8 within the liver. The company was founded in 2016 and maintains its principal offices in Seattle, Washington.
Cena akcji
$5.87
Ostatnia synchronizacja: 2022-11-08
Kapitalizacja rynkowa
$550.43M
Zmiana (1 dzień)
1.03%
Zmiana (1 rok)
0.00%
Kraj
US
Handel Silverback Therapeutics, Inc. (SBTX)

Kategoria

Healthcare
Historia stopy dywidendy dla Silverback Therapeutics, Inc. (SBTX)
Stopa dywidendy (TTM) dla Silverback Therapeutics, Inc. (symbol akcji: SBTX) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Silverback Therapeutics, Inc. (SBTX) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji
Firma Stopa dywidendy Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH